The tumour suppressor protein prostate apoptosis response-4 (PAR-4) is frequently down regulated in many cancers, including renal cancer8, neuroblastoma9, endometrial carcinoma10–12, lung adenocarcinoma13,14, prostate carcinoma15, and breast cancer16–19. This evidence concerns the gene PAWR and cancer.